AllianceBernstein’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-41,300
| Closed | -$373K | – | 3342 |
|
2024
Q1 | $373K | Buy |
41,300
+2,030
| +5% | +$18.4K | ﹤0.01% | 2720 |
|
2023
Q4 | $427K | Buy |
39,270
+4,580
| +13% | +$49.8K | ﹤0.01% | 2687 |
|
2023
Q3 | $279K | Buy |
34,690
+8,700
| +33% | +$70K | ﹤0.01% | 2824 |
|
2023
Q2 | $282K | Buy |
+25,990
| New | +$282K | ﹤0.01% | 2890 |
|
2022
Q2 | – | Sell |
-20,024
| Closed | -$187K | – | 3405 |
|
2022
Q1 | $187K | Hold |
20,024
| – | – | ﹤0.01% | 2998 |
|
2021
Q4 | $238K | Hold |
20,024
| – | – | ﹤0.01% | 3006 |
|
2021
Q3 | $228K | Hold |
20,024
| – | – | ﹤0.01% | 3045 |
|
2021
Q2 | $359K | Buy |
20,024
+2,000
| +11% | +$35.9K | ﹤0.01% | 2949 |
|
2021
Q1 | $279K | Sell |
18,024
-3,900
| -18% | -$60.4K | ﹤0.01% | 2922 |
|
2020
Q4 | $267K | Buy |
+21,924
| New | +$267K | ﹤0.01% | 2899 |
|
2020
Q3 | – | Sell |
-26,075
| Closed | -$265K | – | 3209 |
|
2020
Q2 | $265K | Buy |
26,075
+12,850
| +97% | +$131K | ﹤0.01% | 2921 |
|
2020
Q1 | $107K | Buy |
13,225
+6,950
| +111% | +$56.2K | ﹤0.01% | 2939 |
|
2019
Q4 | $54K | Hold |
6,275
| – | – | ﹤0.01% | 3084 |
|
2019
Q3 | $39K | Hold |
6,275
| – | – | ﹤0.01% | 3126 |
|
2019
Q2 | $104K | Buy |
6,275
+2,250
| +56% | +$37.3K | ﹤0.01% | 3072 |
|
2019
Q1 | $67K | Sell |
4,025
-3,025
| -43% | -$50.4K | ﹤0.01% | 3059 |
|
2018
Q4 | $81K | Hold |
7,050
| – | – | ﹤0.01% | 3006 |
|
2018
Q3 | $282K | Buy |
7,050
+1,850
| +36% | +$74K | ﹤0.01% | 2862 |
|
2018
Q2 | $147K | Buy |
+5,200
| New | +$147K | ﹤0.01% | 3008 |
|